1. Home
  2. MYGN vs GMTL Comparison

MYGN vs GMTL Comparison

Compare MYGN & GMTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$3.05

Market Cap

444.2M

Sector

Health Care

ML Signal

HOLD

Logo Guardian Metal Resources PLC ADS

GMTL

Guardian Metal Resources PLC ADS

N/A

Current Price

$13.00

Market Cap

369.4M

ML Signal

N/A

Company Overview

Basic Information
Metric
MYGN
GMTL
Founded
1991
2021
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Metal Mining
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
444.2M
369.4M
IPO Year
1996
2024

Fundamental Metrics

Financial Performance
Metric
MYGN
GMTL
Price
$3.05
$13.00
Analyst Decision
Buy
Buy
Analyst Count
7
2
Target Price
$7.64
$30.00
AVG Volume (30 Days)
2.4M
223.9K
Earning Date
05-05-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$771,400,000.00
N/A
Revenue This Year
$6.86
N/A
Revenue Next Year
$5.45
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.33
N/A
52 Week Low
$2.74
$8.60
52 Week High
$8.59
$22.21

Technical Indicators

Market Signals
Indicator
MYGN
GMTL
Relative Strength Index (RSI) 27.39 56.40
Support Level $2.74 $12.64
Resistance Level $5.52 $17.88
Average True Range (ATR) 0.25 1.04
MACD -0.11 0.48
Stochastic Oscillator 10.94 84.27

Price Performance

Historical Comparison
MYGN
GMTL

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

About GMTL Guardian Metal Resources PLC ADS

Guardian Metal Resources PLC focuses on metals exploration and development, with a focus on precious metals exploration in North America. The Company has one business segment, which is the exploration and evaluation of mineral resources in Nevada, USA. Its exploration projects comprise the Pilot Mountain Project, Tempiute Project, Golconda Summit Project, Stonewall Project, and Garfield Project, and the Group is the operator of the Golconda Summit Project.

Share on Social Networks: